Nektar Therapeutics buy melinda
Start price
20.06.13
/
50%
€8.20
Target price
20.12.13
€9.00
Performance (%)
-4.06%
End price
20.12.13
€7.87
Summary
This prediction ended on 20.12.13 with a price of €7.87. With a performance of -4.06%, the BUY prediction for Nektar Therapeutics by melinda closed slightly in the red. melinda has 50% into this predictionNektar is a clinical-stage biopharmaceutical company focused on developing treatments for cancer, autoimmune diseases, and chronic pain. The company's pipeline includes product candidates based on its proprietary drug delivery technology, which improves the delivery and effectiveness of drugs in the body. Some of its most advanced candidates include NKTR-214, a cancer immunotherapy, and NKTR-181, a non-opioid pain medication. Nektar is listed on the NASDAQ exchange under the ticker symbol NKTR.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Nektar Therapeutics | -1.229% | -1.229% | 139.636% | -89.171% |
| iShares Core DAX® | 0.051% | 5.593% | 14.403% | 19.767% |
| iShares Nasdaq 100 | 1.808% | 7.445% | 34.917% | 57.237% |
| iShares Nikkei 225® | 2.181% | 2.815% | 11.116% | 8.873% |
| iShares S&P 500 | 1.040% | 4.975% | 27.631% | 48.786% |
Comments by melinda for this prediction
In the thread Nektar Therapeutics diskutieren
Übersetzung fehlgeschlagen
Die Übersetzung durch Google Translate ist leider fehlgeschlagen.
(Laufzeit überschritten)
Stopped prediction by melinda for Nektar Therapeutics
Nektar Therapeutics
Start price
Target price
Perf. (%)
€75.16
16.05.18
16.05.18
€90.20
08.11.18
08.11.18
-56.56%
08.11.18
08.11.18
Nektar Therapeutics
Start price
Target price
Perf. (%)
€45.02
21.11.17
21.11.17
€49.61
29.12.17
29.12.17
21.22%
29.12.17
29.12.17
Nektar Therapeutics
Start price
Target price
Perf. (%)
€49.91
21.11.17
21.11.17
€55.00
29.12.17
29.12.17
21.22%
29.12.17
29.12.17